CA2336285A1 - Aryl phosphate derivatives of d4t having anti-hiv activity - Google Patents

Aryl phosphate derivatives of d4t having anti-hiv activity Download PDF

Info

Publication number
CA2336285A1
CA2336285A1 CA002336285A CA2336285A CA2336285A1 CA 2336285 A1 CA2336285 A1 CA 2336285A1 CA 002336285 A CA002336285 A CA 002336285A CA 2336285 A CA2336285 A CA 2336285A CA 2336285 A1 CA2336285 A1 CA 2336285A1
Authority
CA
Canada
Prior art keywords
compound
formula
aryl
cells
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002336285A
Other languages
English (en)
French (fr)
Inventor
Fatih M. Uckun
Rakesh Vig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336285A1 publication Critical patent/CA2336285A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002336285A 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity Abandoned CA2336285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/107,716 US6030957A (en) 1998-06-29 1998-06-29 Aryl phosphate derivatives of d4T having anti-HIV activity
US09/107,716 1998-06-30
PCT/US1999/014774 WO2000000501A1 (en) 1998-06-29 1999-06-29 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY

Publications (1)

Publication Number Publication Date
CA2336285A1 true CA2336285A1 (en) 2000-01-06

Family

ID=22318071

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336285A Abandoned CA2336285A1 (en) 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity

Country Status (14)

Country Link
US (7) US6030957A (https=)
EP (1) EP1090018B1 (https=)
JP (1) JP2002519355A (https=)
KR (1) KR20010071673A (https=)
CN (1) CN1314909A (https=)
AT (1) ATE277940T1 (https=)
AU (1) AU4846999A (https=)
BR (1) BR9911685A (https=)
CA (1) CA2336285A1 (https=)
DE (1) DE69920696T2 (https=)
HU (1) HUP0102527A3 (https=)
IL (1) IL140388A0 (https=)
NO (1) NO20006685L (https=)
WO (1) WO2000000501A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
AU3897800A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute One pot synthesis of 5'-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
DK1334108T3 (da) * 2000-11-13 2005-07-11 Parker Hughes Inst Arylfosfatderivater af d4T
CA2487419A1 (en) * 2002-05-28 2003-12-04 Regents Of The University Of Minnesota Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
US20040076931A1 (en) * 2002-10-18 2004-04-22 Cashflow Technologies, Inc. Educational interactive games
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
EP1773355B1 (en) * 2004-06-24 2014-06-25 Merck Sharp & Dohme Corp. Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
WO2006026656A1 (en) * 2004-08-31 2006-03-09 Parker Hughes Institute Cytotoxic nucleoside analog compound 003 for treating cancer
CA2589935A1 (en) 2004-12-09 2006-06-15 Regents Of The University Of Minnesota Nucleosides with antiviral and anticancer activity
EP1866064A4 (en) * 2005-03-09 2009-08-19 Univ California NANOCOMPOSITE MEMBRANES AND METHOD FOR THE PRODUCTION AND USE THEREOF
US7892618B2 (en) * 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
AU2010226466A1 (en) * 2009-03-20 2011-10-20 Alios Biopharma, Inc. Substituted nucleoside and nucleotide analogs
BR112013005872A2 (pt) 2010-09-22 2019-09-24 Alios Biopharma Inc compostos, composição farmacêutica e respectivos usos
US9095599B2 (en) 2011-01-03 2015-08-04 Nanjing Molecular Research, Inc. O-(substituted benzyl) phosphoramidate compounds and therapeutic use
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
AU2014250762A1 (en) 2013-04-12 2015-10-29 Achillion Pharmaceuticals, Inc. Highly active nucleoside derivative for the treatment of HCV

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707362A (en) 1985-02-15 1987-11-17 Biotek, Inc. Sustained release composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
JPH06189998A (ja) 1992-11-06 1994-07-12 C & Co:Yugen コンド―ム
AU5691094A (en) 1992-12-18 1994-07-19 University Of Alberta, The Dihydropyrimidine nucleosides with antiviral properties
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5659023A (en) * 1995-02-01 1997-08-19 Gilead Sciences, Inc. Nucleotide analogues
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
AP1406A (en) 1996-05-09 2005-05-04 Infectio Recherche Inc Formulations for use in the prevention of pathogen induced diseases including HIV and HSV.
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity

Also Published As

Publication number Publication date
KR20010071673A (ko) 2001-07-31
ATE277940T1 (de) 2004-10-15
US6528495B1 (en) 2003-03-04
JP2002519355A (ja) 2002-07-02
DE69920696T2 (de) 2006-03-02
US6030957A (en) 2000-02-29
US6503890B1 (en) 2003-01-07
BR9911685A (pt) 2001-12-18
EP1090018B1 (en) 2004-09-29
WO2000000501A1 (en) 2000-01-06
DE69920696D1 (de) 2004-11-04
US6350736B1 (en) 2002-02-26
NO20006685D0 (no) 2000-12-28
NO20006685L (no) 2001-02-28
AU4846999A (en) 2000-01-17
EP1090018A1 (en) 2001-04-11
HUP0102527A3 (en) 2002-04-29
US7071176B2 (en) 2006-07-04
IL140388A0 (en) 2002-02-10
CN1314909A (zh) 2001-09-26
US20040171577A1 (en) 2004-09-02
HUP0102527A2 (hu) 2001-12-28
US6537975B1 (en) 2003-03-25
US6670336B1 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
US6503890B1 (en) Aryl phosphate derivatives of d4T having anti-HIV activity
EP0820461B1 (en) Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides
US4963662A (en) Fluorinated nucleosides and method for treating retrovirus infections therewith
EP0707481B1 (en) L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents
US4788181A (en) 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
CA2476282A1 (en) Dosing regimen for gemcitabine hcv therapy
SK281826B6 (sk) Deriváty fosfolipidov nukleozidov, ich použitie a farmaceutický prostriedok na ich báze
JP2005524662A (ja) ヌクレオシド５’−一リン酸模倣物およびこれらのプロドラッグ
JPH03148292A (ja) Ｂ型肝炎に対する製薬剤として、ピリミジンヌクレオシド及びプリンヌクレオシドを製造する為の方法及びその使用法
US4857511A (en) Treatment of human viral infections
IE63561B1 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
US5153180A (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
US5132414A (en) Dideoxynucleoside-5'-phosphonoformic acid compounds
MXPA00013013A (en) ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY
AU2001232701A1 (en) Aryl phosphate derivatives of d4t
US20040087549A1 (en) Aryl phosphate derivatives of d4T having activity against resistant HIV strains
MXPA97006942A (en) Quimi compounds
HK1013257B (en) L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued